APA (7th ed.) Citation

TK, C., J, L., S, P., RJ, M., BI, R., B, V., . . . L, A. (2021). Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: Post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]. ESMO open, 6(4), 100177. https://doi.org/10.1016/j.esmoop.2021.100177

Chicago Style (17th ed.) Citation

TK, Choueiri, et al. "Erratum to 'Efficacy and Correlative Analyses of Avelumab Plus Axitinib Versus Sunitinib in Sarcomatoid Renal Cell Carcinoma: Post Hoc Analysis of a Randomized Clinical Trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]." ESMO Open 6, no. 4 (2021): 100177. https://doi.org/10.1016/j.esmoop.2021.100177.

MLA (9th ed.) Citation

TK, Choueiri, et al. "Erratum to 'Efficacy and Correlative Analyses of Avelumab Plus Axitinib Versus Sunitinib in Sarcomatoid Renal Cell Carcinoma: Post Hoc Analysis of a Randomized Clinical Trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]." ESMO Open, vol. 6, no. 4, 2021, p. 100177, https://doi.org/10.1016/j.esmoop.2021.100177.